Literature DB >> 19436570

Genotypic investigation of Clostridium difficile in Prince Edward Island.

H Martin1, L P Abbott, D E Low, B Willey, M Mulvey, J Scott Weese.   

Abstract

Clostridium difficile is an important cause of disease in Canada; however, little information is available about the disease in the Maritime provinces. The objective of the present study was to characterize C difficile isolates obtained from people hospitalized with C difficile infection in Prince Edward Island. One hundred twenty-six C difficile ELISA toxin-positive stool samples were obtained and cultured using an enrichment protocol. C difficile was isolated from 105 of 126 (83%) samples. Twenty-two different ribotypes were identified. The most common ribotype, ribotype W, was a North American pulsotype 2 (NAP2), toxinotype 0 strain, which represented 18% of isolates. The next most common ribotype was a NAP1, toxinotype III strain, which accounted for 11% of isolates. Ribotype 027/NAP1 only accounted for five (4.7%) isolates. Forty-five per cent of isolates possessed genes encoding production of binary toxin. Three different ribotypes, all NAP1, toxinotype III strains, had a frameshift mutation in the tcdC gene (Delta117), while one isolate (ribotype 078, NAP4, toxinotype V) had a truncating mutation (C184T) in the tcdC gene.

Entities:  

Keywords:  Clostridium difficile; Microbiology; Molecular epidemiology

Year:  2008        PMID: 19436570      PMCID: PMC2663471          DOI: 10.1155/2008/848045

Source DB:  PubMed          Journal:  Can J Infect Dis Med Microbiol        ISSN: 1712-9532            Impact factor:   2.471


  30 in total

1.  A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality.

Authors:  Vivian G Loo; Louise Poirier; Mark A Miller; Matthew Oughton; Michael D Libman; Sophie Michaud; Anne-Marie Bourgault; Tuyen Nguyen; Charles Frenette; Mirabelle Kelly; Anne Vibien; Paul Brassard; Susan Fenn; Ken Dewar; Thomas J Hudson; Ruth Horn; Pierre René; Yury Monczak; André Dascal
Journal:  N Engl J Med       Date:  2005-12-01       Impact factor: 91.245

2.  Clostridium difficile PCR ribotype 078: an emerging strain in humans and in pigs?

Authors:  Abraham Goorhuis; Sylvia B Debast; Leo A M G van Leengoed; Celine Harmanus; Daan W Notermans; Aldert A Bergwerff; Edward J Kuijper
Journal:  J Clin Microbiol       Date:  2008-03       Impact factor: 5.948

3.  A portrait of the geographic dissemination of the Clostridium difficile North American pulsed-field type 1 strain and the epidemiology of C. difficile-associated disease in Québec.

Authors:  Bruno Hubert; Vivian G Loo; Anne-Marie Bourgault; Louise Poirier; André Dascal; Elise Fortin; Marc Dionne; Manon Lorange
Journal:  Clin Infect Dis       Date:  2006-12-06       Impact factor: 9.079

4.  Binary toxin producing Clostridium difficile strains.

Authors:  M Rupnik; M Grabnar; B Geric
Journal:  Anaerobe       Date:  2003-12       Impact factor: 3.331

5.  tcdC genotypes associated with severe TcdC truncation in an epidemic clone and other strains of Clostridium difficile.

Authors:  Scott R Curry; Jane W Marsh; Carlene A Muto; Mary M O'Leary; A William Pasculle; Lee H Harrison
Journal:  J Clin Microbiol       Date:  2006-10-11       Impact factor: 5.948

6.  Characteristics and incidence of Clostridium difficile-associated disease in The Netherlands, 2005.

Authors:  S Paltansing; R J van den Berg; R A Guseinova; C E Visser; E R van der Vorm; E J Kuijper
Journal:  Clin Microbiol Infect       Date:  2007-11       Impact factor: 8.067

7.  A novel toxinotyping scheme and correlation of toxinotypes with serogroups of Clostridium difficile isolates.

Authors:  M Rupnik; V Avesani; M Janc; C von Eichel-Streiber; M Delmée
Journal:  J Clin Microbiol       Date:  1998-08       Impact factor: 5.948

8.  Identification of toxin A-negative, toxin B-positive Clostridium difficile by PCR.

Authors:  H Kato; N Kato; K Watanabe; N Iwai; H Nakamura; T Yamamoto; K Suzuki; S M Kim; Y Chong; E B Wasito
Journal:  J Clin Microbiol       Date:  1998-08       Impact factor: 5.948

9.  Clostridium difficile toxin expression is inhibited by the novel regulator TcdC.

Authors:  Susana Matamouros; Patrick England; Bruno Dupuy
Journal:  Mol Microbiol       Date:  2007-06       Impact factor: 3.501

10.  Clinical severity of Clostridium difficile PCR ribotype 027: a case-case study.

Authors:  Oliver W Morgan; Boaventura Rodrigues; Tony Elston; Neville Q Verlander; Derek F J Brown; Jonathan Brazier; Mark Reacher
Journal:  PLoS One       Date:  2008-03-19       Impact factor: 3.240

View more
  2 in total

1.  False-Positive Clostridium difficile in Negative-Control Reactions Peak and Then Decrease with Repetitive Refrigeration of Immunoassay.

Authors:  Alexander Rodriguez-Palacios; Henry R Stämpfli; Yung-Fu Chang
Journal:  Int Sch Res Notices       Date:  2014-09-11

2.  Characterization of Clostridium difficile Strains in British Columbia, Canada: A Shift from NAP1 Majority (2008) to Novel Strain Types (2013) in One Region.

Authors:  Agatha N Jassem; Natalie Prystajecky; Fawziah Marra; Pamela Kibsey; Kennard Tan; Patricia Umlandt; Loretta Janz; Sylvie Champagne; Bruce Gamage; George R Golding; Michael R Mulvey; Bonnie Henry; Linda M N Hoang
Journal:  Can J Infect Dis Med Microbiol       Date:  2016-03-29       Impact factor: 2.471

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.